Kinetics and prognostic value of soluble VCAM-1 in ST-segment elevation myocardial infarction patients.

Ahmad HayekAlexandre PaccaletLaura MechtouffClaire C Da SilvaFabrice IvanesHadrien FalqueSimon LeboubeYvonne VarillonCamille AmazCharles de BourguignonCyril PrieurDanka TomasevicNathalie GenotFrançois DerimayEric Bonnefoy-CudrazGabriel BidauxNathan MewtonMichel OvizeThomas Bochaton

Published in: Immunity, inflammation and disease (2021)

In STEMI patients, high sVCAM-1 levels are associated with a poor clinical outcome. sVCAM-1 is an early postmyocardial infarction biomarker and might be an interesting target for the development of future therapeutic strategies.

Keyphrases

st segment elevation myocardial infarction
end stage renal disease
percutaneous coronary intervention
newly diagnosed
ejection fraction
peritoneal dialysis
acute coronary syndrome
st elevation myocardial infarction